According to a new market research study titled ‘‘Clinical Decision Support Systems Market to 2027 – Global Analysis and Forecasts by Component, Delivery Mode, Application, End User and Geography. The global clinical decision support systems market is expected to reach US$ 5,983.38 Mn in 2027 from US$ 2,772.60 Mn in 2018. The market is estimated to grow with a CAGR of 9.2% from 2019-2027. The market is likely to grow due to Rising pressure on healthcare institutions to provide quality health at reduced costs, rising prevalence of chronic diseases, growing adoption of big data & health IT tools, number of initiatives taken by governments, rising developments in the fields of healthcare IT, rising number of hospitals. Whereas, the growth of the market is restrained by factors such as the concerns regarding data privacy.
The clinical decision support system is an emerging market consisting of the good and countable number of players, having considerable revenue in the market. Most of the companies operating in the global clinical decision support systems market offer software systems that enables hospitals staffs and physicians to offers better clinical services. The products also help in managing workflow easily and effectively.
Clinical decision support systems (CDSS) are computer-based programs that are used to analyze the patient data in order to assist the hospitals, clinics, and ambulatory care centers. CDSS analyses the data from EHRs to assist the physicians by providing the prompts and reminders about the patients and their medication. Clinical decision support systems (CDSS) helps the healthcare providers to implement the evidence-based clinical guidelines at the point of care. For instance, Alzheimer prevention, CDSS can be used to facilitate care in various ways, by reminding physicians to check for Alzheimer risk factors, highlighting the cases of high blood pressure, drug dosage timing, and providing customized dosage.